Optimize Participant Identification

Identify patients for even the most complex clinical trial protocols utilizing  secure, HIPAA-compliant technology in concert with TA-specific data sources.

Proactively refine feasibility and inform site selection to decrease the number of under-performing sites, salvage study budgets, and meet timelines to stay competitive as precision medicine accelerates.

Increase clinical trial enrollment and efficiency by locating patients now

clinical trial network

Our team has created trusted relationships with several EMR partners in order to build an expanding Connected Site Network that today includes over 14 million patient records in nearly every therapeutic area.

Learn More

Linking All
Stakeholders

Patient iP has combined innovative technology solutions with an expansive de-identified data network to enable our CRO and sponsor customers to make the most informed study design decisions.

Study Sites

Clinical sites, hospitals, and SMOs benefit from technology that automates patient matching with precision, increases overall process efficiency and drives better patient engagement.

Learn More >

Study Sponsors

From pharmaeutical giants to earlier stage biotech startups, all sponsors can benefit from expedited site selection based upon objective, near-time data and the insights that stem the aggregation of structured EMR data.

Learn More >

Want to find
out more?

Our video shows how Patient IP connects stakeholders in a meaningful way, creating a true link that benefits patients, study sites, and sponsors.

July 25, 2017 in News, Uncategorized

Patient identification Platform and Aprima Announce Strategic Partnership to Improve Clinical Trial Recruitment Efforts

Rochester, NY – July 25, 2017 – Patient identification Platform (Patient iP), an emerging health data solutions provider to the pharmaceutical and CRO industries, today announced a new partnership with…

Read More
July 11, 2017 in News

Patient identification Platform Data Network Surpasses 14 Million Unique Patients Lives, Achieving Significant Growth Milestone

Rochester, NY – July 11, 2017 – Patient identification Platform (Patient iP), an emerging health data network supplier to the pharmaceutical and CRO industries, today announced that the company’s Connected…

Read More

Winner of the 2016 Microsoft Health Innovation Award

The Patient identification Platform (Patient iP) automates the historically time-intensive process of clinical trial matching for subject participation. The Platform securely de-identifies and aggregates electronic health record data so that clinical trial protocols can be automatically processed, rapidly identifying where and how many patients match the criteria requirements.